Baculovirus Merozoite Surface Protein 1 C-Terminal Recombinant Antigens Are Highly Protective in a Natural Primate Model for Human Plasmodium vivax Malaria

Infection and Immunity

Volumn 66, Issue 4, 1998, Pages 1500-1506

  Perera, K L R Lakshman ^a   Handunnetti, Shiroma M ^a   Holm, Inge ^b   Longacre, Shirley ^b   Mendis, Kamini ^a,c  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

^b INSTITUT PASTEUR   (France)

^c Faculty of Management Colombo International Nautical and Engineering College CINEC Campus   (Sri Lanka)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 1; PARASITE ANTIGEN; PROTEIN PRECURSOR; PROTOZOAL PROTEIN; RECOMBINANT VACCINE;

ANIMAL; ARTICLE; BACULOVIRUS; GENETICS; HUMAN; IMMUNOLOGY; MACACA; MALARIA;

ANIMALS; ANTIGENS, PROTOZOAN; BACULOVIRIDAE; HUMANS; MACACA; MALARIA VACCINES; MALARIA, VIVAX; MEROZOITE SURFACE PROTEIN 1; PROTEIN PRECURSORS; PROTOZOAN PROTEINS; VACCINES, SYNTHETIC;

EID: 0032037593     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.4.1500-1506.1998     Document Type: Article

References (46)

1. Anonymous. 1992. Annual administrative report of the anti-malaria campaign. Ministry of Health, Colombo Sri Lanka.
2. Barnwell, J. W., et al. Unpublished data.
3. Boyd, M. F. 1942. Criteria of immunity and susceptibility in naturally acquired and induced vivax malaria infections. Am. J. Trop. Med. Hyg. 22: 217-227.
4. Chang, S. P., S. E. Case, W. L. Gosnell, A. Hashimoto, K. J. Kramer, L. Q. Tam, C. Q. Hashiro, C. M. Nikaido, H. L. Gibson, C. T. Lee-Ng, P. J. Barr, B. T. Yokota, and G. S. N. Hui. 1996. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria. Infect. Immun. 64:253-261.
5. Coatney, G. R., W. E. Collins, M. Warren, and P. G. Contacos. 1971. The primate malarias. U.S. Government Printing Office, Washington, D.C.
6. Collins, W. E., and M. Aikawa. 1993. Plasmodia of nonhuman primates, p. 105-133. In J. P. Kreier (ed.), Parasitic protozoa, vol. 5. Academic Press, San Diego, Calif.
7. Cooper, J. A. 1993. Merozoite surface antigen-1 of Plasmodium. Parasitol. Today 9:50-54.
8. Daly, T. M., and C. A. Long. 1993. A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice. Infect. Immun. 61:2462-2467.
9. David, P. H., J. W. Barnwell, and K. N. Mendis. 1990. Vivax malaria - strategies for vaccine development based on the hepatic, asexual erythrocytic, and sexual stages, p. 531-543. In G. C. Woodrow and M. M. Levine (ed.), New generation vaccines. Marcel Dekker, New York, N.Y.
10. Del Portillo, H. A., S. Longacre, E. Khouri, and P. H. David. 1991. Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species. Proc. Natl. Acad. Sci. USA 88:4030-4034.
11. Diggs, C. L., W. R. Ballou, and L. H. Miller. 1993. The major merozoite surface protein as a malaria vaccine target. Parasitol. Today 9:300-302.
12. Dissanaike, A. S., P. Nelson, and P. C. C. Garnham. 1965. Two new malaria parasites, Plasmodium cynomolgi ceylonensis subsp. nov., and Plasmodium fragile sp. nov., from monkeys in Ceylon. Ceylon Med. J. Sci. 14: 1-9.
13. Dua, V. K., P. K. Kar, and V. P. Sharma. 1996. Chloroquine resistant Plasmodium max malaria in India. Trop. Med. Int. Health 1:816-819.
14. Escalante, A. A., and F. J. Ayala. 1994. Phylogeny of the malarial genus Plasmodium, derived from rRNA gene sequences. Proc. Natl. Acad. Sci. USA 91:11373-11377.
15. Fang, X., D. C. Kaslow, J. H. Adams, and L. H. Miller. 1991. Cloning of the Plasmodium vivax Duffy receptor. Mol. Biochem. Parasitol. 44:125-132.
16. Galinski, M. R., D. E. Arnot, A. H. Cochrane, J. W. Barnwell, R. S. Nussenzweig, and V. Enea. 1987. The circumsporozoite gene of the Plasmodium cynomolgi complex. Cell 48:311-319.
17. Garavelli, P. L., and E. Corli. 1992. Chloroquine resistance in Plasmodium vivax: the first case in Brazil. Trans. R. Soc. Trop. Med. Hyg. 86:128.
18. Garg, M., N. Gopinathan, P. Bodhe, and N. Kshirsagar. 1995. Vivax malaria resistant to chloroquine: case report from Bombay. Trans. R. Soc. Trop. Med. Hyg. 89:656-657.
19. Garnham, P. C. C. 1966. Malaria parasites and other hemosporidia. Blackwell, Oxford, United Kingdom.
20. Hamilton, D. K., and D. Pikacha. 1982. Ruptured spleen in a malarious area. Aust. N. Zealand Surg. 52:310-313.
21. Handunnetti, S. M. 1986. An exploration into immunity in a natural malaria infection: Plasmodium fragile in the toque monkey Macaca sinica. Ph.D. thesis. University of Colombo, Colombo, Sri Lanka.
22. Holder, A. A. 1988. The precursor to major merozoite surface antigens: structure and role in immunity. Prog. Allergy 41:72-97.
23. Holm, I., F. Nato, K. N. Mendis, and S. Longacre. 1997. Characterization of C-terminal merozoite surface protein 1 baculovirus recombinant proteins from Plasmodium vivax and Plasmodium cynomolgi as recognised by the natural anti-parasite immune response. Mol. Biochem. Parasitol. 89:313-319.
24. Ihalamulla, R. L., and K. N. Mendis. 1987. Plasmodium vivax: isolation of mature asexual stages and gametocytes from infected human blood by colloidal silica (Percoll) gradient centrifugation. Trans. R. Soc. Trop. Med. Hyg. 81:25-28.
25. Jeffery, G. M. 1966. Epidemiological significance of repeated infections with homologous and heterologous strains and species of Plasmodium. Bulletin W. H. O. 35:873-882.
26. Jiang, J. B., Y. Sy, and J. M. Chen. 1965. A new strain of Plasmodium vivax endemic to China. Acta Sci. Nat. Univ. Sunyatseni 1:131-132.
27. Kumar, S., A. Yadava, D. B. Keister, J. H. Tian, M. Ohl, K. A. Perdue-Greenfield, L. H. Miller, and D. C. Kaslow. 1995. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. Mol. Med. 1:325-332.
28. Ling, I. T., S. A. Ogun, and A, A. Holder. 1994. Immunization against malaria with a recombinant protein. Parasite Immunol. 16:63-67.
29. Longacre, S. 1995. The Plasmodium cynomolgi merozoite surface protein 1 C-terminal sequence and its homologies with other Plasmodium species. Mol. Biochem. Parasitol. 74:105-111.
30. Longacre, S., K. N. Mendis, and P. H. David. 1994. Plasmodium vivax merozoite surface protein 1 C-terminal recombinant proteins in baculovirus. Mol. Biochem. Parasitol. 64:191-205.
31. McCutchan, T. F., J. B. Dame, L. H. Miller, and J. W. Barnwell. 1984. Evolutionary relatedness of Plasmodium species as determined by the structure of DNA. Science 225:808-811.
32. Mendis, K. N. 1995. Simian malaria models for research on human disease. Ceylon Med. J. Sci. 38(2):31-35.
33. Naotunne, T. D. S. 1990. A study of factors modulating infectivity of sexual stage malaria parasites: Plasmodium cynomolgi ceylonensis in Macaca sinica sinica. Ph.D. thesis. University of Colombo, Colombo, Sri Lanka.
34. Naotunne, T. D. S., N. D. Karunaweera, G. Del Giudice, B. D. M. U. Kularatne, G. E. Grau, R. Carter, and K. N. Mendis. 1991. Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential. J. Exp. Med. 173:523-529.
35. Naotunne, T. D. S., K. D. L. Rathnayake, A. Jayasinghe, R. Carter, and K. N. Mendis. 1990. Plasmodium cynomolgi: serum-mediated blocking and enhancement of infectivity to mosquitoes during infections in the natural host, Macaca sinica. Exp. Parasitol. 71:305-313.
36. Nelson, P., J. M. R. Jayasuriya, and B. V. P. C. Bandarawatta. 1971. The establishment of Anopheles elegans as the natural vector of simian malaria in Ceylon. Ceylon Med. J. Sci. 20:46-51.
37. Peiris, J. S. M., S. Premawansa, M. B. R. Ranawaka, P. V. Udagama, Y. D. Munesinghe, M. V. Nanayakkara, C. P. Gamage, R. Carter, P. H. David, and K. N. Mendis. 1988. Monoclonal and polyclonal antibodies both block and enhance transmission of human Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 39:26-32.
38. Perera, K. L. R. L., et al. Unpublished data.
39. Riley, E. M., S. J. Allen, J. G. Wheeler, M. J. Blackman, S. Bennett, B. Takacs, H. J. Schoenfeld, A. A. Holder, and B. M. Greenwood. 1992. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol. 14:321-337.
40. Schuurkamp, G. J., P. E. Spicer, R. K. Kereu, P. K. Bulungol, and K. H. Rieckmann. 1992. Chloroquine-resistant Plasmodium vivax in Papua New Guinea. Trans. R. Soc. Trop. Med. Hyg. 86:121-122.
41. Siddiqui, W. A., L. Q. Tam, K. J. Kramer, G. S. Hui, S. E. Case, K. M. Yamaga, S. P. Chang, and E. B. Chan. 1987. Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria. Proc. Natl. Acad. Sci. USA 84:3014-3018.
42. Snounou, G., S. Viriyakosol, X. P. Zhu, W. Jarra, L. Pinheiro, V. E. D. Rusario, S. Thaithong, and K. N. Brown. 1993. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol. Biochem. Parasitol. 61:315-320.
43. Stoute, J. A., M. Slaoui, G. Heppner, P. Momin, K. E. Kester, P. Desmons, B. T. Wellde, N. Garcon, U. Krzych, M. Marchand, W. R. Ballou, and J. W. Cohen. 1997. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. N. Engl. J. Med. 336:86-91.
44. Udagama, P. V., P. H. David, J. S. M. Peiris, Y. G. Ariyaratne, K. L. R. L. Perera, and K. N. Mendis. 1987. Demonstration of antigenic polymorphism in Plasmodium vivax malaria with a panel of 30 monoclonal antibodies. Infect. Immun. 55:2604-2611.
45. Valecha, N., A. Bagga, J. Chandra, and D. Sharma. 1992. Cerebral symptoms with P. vivax malaria. Indian Pediatr. 29:1176-1178.
46. Waters, A. P., D. G. Higgins, and T. F. McCutchan. 1993. Evolutionary relatedness of some primate models of Plasmodium. Mol. Biol. Evol. 10: 914-923.